Serum metalloproteinases and their inhibitors: markers for malignant potential.
about
Increased serum proMMP-3 in inflammatory arthritides: a potential indicator of synovial inflammatory monokine activity.Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications.Novel strategies and therapeutics for the treatment of prostate carcinoma.Adjuvant chemo-/hormonal therapy trials for locally advanced prostate cancer.Functional protease profiling for diagnosis of malignant disease.A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphomaLevels of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 in gastric cancer.Serum levels of tissue inhibitors of metalloproteinase 2 in patients with systemic sclerosis with duration more than 2 years: correlation with cardiac and pulmonary abnormalities.Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms.Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.14-3-3 proteins modulate the ETS transcription factor ETV1 in prostate cancer.Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolytically-active tryptase is a potent fibrogenic factor.Molecular biology of prostatic intraepithelial neoplasia.Metastatic colorectal cancer cells induce matrix metalloproteinase release by human monocytes.Diagnostic and prognostic markers for human prostate cancer.Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation.Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET.Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer.The effects of sustained elevated levels of circulating tissue inhibitor of metalloproteinases-1 on the development of breast cancer in mice.miR-618: possible control over TIMP-1 and its expression in localized prostate cancer
P2860
Q33566805-DA38D50C-9922-4C10-9DD8-B1E0733848CFQ33692926-A2A0F5BA-50BA-4659-9B22-929A38743696Q34043331-8934AF45-9088-4542-8328-E0C88E0B051DQ34108014-53DC9CEE-C0F4-4DE7-86C4-04E5D80757F0Q34116114-59BBBD43-88D5-4B2C-A856-12FE083880D0Q34210085-E5FEC333-70C0-407E-935E-07D3AD52FB7DQ34884623-B5BC53D7-13CB-4AB9-9FDB-32887E1A09AAQ35598573-22EC43F9-6DEA-4560-8578-E14AB4A9F9D9Q36421987-EEBE4516-10BF-43BE-A18E-525CB10FD11DQ36617818-6115B785-3FA4-4B6C-9B34-75EEF664A4E7Q37100125-DDB8B6FA-3FEF-4784-A60D-05E365024C22Q40375490-929FBAC5-D904-4BC6-8A18-502ACA06829DQ40729503-F0414E98-6423-4703-951F-ADBE72C6CC46Q40927110-331B13A3-08D4-406F-87F4-0336A0EDD6F6Q41028756-6C3C9EA3-AD04-4E9E-939C-3FE7D1DFABDAQ41257383-93D27798-231B-4612-8174-27D92F122E10Q41495930-2445809F-0C5F-4191-A840-54115034B7ECQ42499209-2AD8327C-E00C-4E52-8BD8-F5CADCE00635Q43548143-22A5E8D9-07DD-404E-ADC3-64767F8C91F0Q46680514-B4CA69B8-53A3-4B67-8BB9-D4DDE309AFC4Q53000471-A6AF6AB1-3F2C-4667-A0D3-BB220F99703CQ53421209-0E4C6C8C-E549-48DA-93D8-D5A215E9D968Q57809343-1BBA1418-A8F1-4FB0-B657-EFF1DAC2DC65
P2860
Serum metalloproteinases and their inhibitors: markers for malignant potential.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@ast
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@en
type
label
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@ast
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@en
prefLabel
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@ast
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@en
P2093
P2860
P356
P1476
Serum metalloproteinases and their inhibitors: markers for malignant potential.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1994.336
P407
P577
1994-09-01T00:00:00Z